NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT01271959 2012-10-05A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyPrecision TherapeuticsTerminated167 enrolled